Review



nrg1β1  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems nrg1β1
    Evaluation of Rgs16 expression in acute and chronic injury and after <t>NRG1β1</t> stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.
    Nrg1β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 108 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nrg1β1/product/R&D Systems
    Average 95 stars, based on 108 article reviews
    nrg1β1 - by Bioz Stars, 2026-06
    95/100 stars

    Images

    1) Product Images from "Dynamic regulation of Rgs16 and its correlation with Neuregulin1 expression in acute and chronic nerve injury"

    Article Title: Dynamic regulation of Rgs16 and its correlation with Neuregulin1 expression in acute and chronic nerve injury

    Journal: Frontiers in Cell and Developmental Biology

    doi: 10.3389/fcell.2025.1540453

    Evaluation of Rgs16 expression in acute and chronic injury and after NRG1β1 stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.
    Figure Legend Snippet: Evaluation of Rgs16 expression in acute and chronic injury and after NRG1β1 stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.

    Techniques Used: Expressing, Quantitative Proteomics, Quantitative RT-PCR, Gene Expression, RNA Sequencing, Western Blot



    Similar Products

    95
    R&D Systems nrg1β1
    Evaluation of Rgs16 expression in acute and chronic injury and after <t>NRG1β1</t> stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.
    Nrg1β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nrg1β1/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    nrg1β1 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    94
    R&D Systems serum nrg1β1 levels
    <t>NRG1β1</t> levels in the patient and control groups before and after antipsychotic drug treatment
    Serum Nrg1β1 Levels, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/serum nrg1β1 levels/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    serum nrg1β1 levels - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    95
    R&D Systems recombinant human nrg1β1 active domain
    <t>NRG1β1</t> levels in the patient and control groups before and after antipsychotic drug treatment
    Recombinant Human Nrg1β1 Active Domain, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human nrg1β1 active domain/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    recombinant human nrg1β1 active domain - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    R&D Systems recombinant human nrg1β1
    <t>NRG1β1</t> levels in the patient and control groups before and after antipsychotic drug treatment
    Recombinant Human Nrg1β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human nrg1β1/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    recombinant human nrg1β1 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    R&D Systems nrg1β1 t176 k246
    <t>NRG1β1</t> levels in the patient and control groups before and after antipsychotic drug treatment
    Nrg1β1 T176 K246, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/nrg1β1 t176 k246/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    nrg1β1 t176 k246 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    95
    R&D Systems recombinant nrg1β1
    <t>NRG1β1</t> levels in the patient and control groups before and after antipsychotic drug treatment
    Recombinant Nrg1β1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant nrg1β1/product/R&D Systems
    Average 95 stars, based on 1 article reviews
    recombinant nrg1β1 - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    Image Search Results


    Evaluation of Rgs16 expression in acute and chronic injury and after NRG1β1 stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: Dynamic regulation of Rgs16 and its correlation with Neuregulin1 expression in acute and chronic nerve injury

    doi: 10.3389/fcell.2025.1540453

    Figure Lengend Snippet: Evaluation of Rgs16 expression in acute and chronic injury and after NRG1β1 stimulation of Schwann cells. (A–C) Quantitative expression analysis of Rgs16 under regenerating and degenerating conditions following traumatic injury to the median nerve in Wistar rats. The relative quantification of Rgs16 was evaluated by qRT-PCR at different time points after injury (d = day post-injury). Regenerating conditions: (A) crush injury; (B) end-to-end repair after transection injury. Degenerating conditions: (C) transection injury. The geometric mean of the housekeeping genes Ankrd27 and Rictor was used to normalize data. The healthy nerves were used as calibrator. The values in the graphs are expressed as the mean ± SEM (n = 3-6 each group). (D) Comparative analysis of Rgs gene expression in rat Schwann cells after chronic constriction injury obtained from single-cell RNA sequencing dataset. The heatmap shows average expression levels of the Rgs gene family for uninjured (Un) versus 3 days post-injury (3d) and 12 days post-injury (12d) conditions. The table below presents adjusted p-values from Wilcoxon and Likelihood-ratio (bimodal) tests for Rgs16 , indicating significant differential expression. (E, F) Normalized counts of RNA-sequencing data of Rgs16 and Nrg1 genes in a model of chronic demyelinating pathology Charcot-Marie-Tooth disease type-1A during development. The values in the graphs are expressed as the mean ± SEM (n = 4 each group). (G) Quantitative expression analysis by qRT-PCR of Rgs16 after 10 nM NRG1β1 stimulation of Schwann cells. Tbp was used as a housekeeping gene to normalize data. Untreated cells were used as calibrator. The values in the graph are expressed as the mean ± SEM (n = 3 each group). (H) Western blot analysis of RGS16 after 10 nM NRG1β1 stimulation of primary cultures of Schwann cells at different time points.

    Article Snippet: Cells were centrifuged at 100 rcf for 5 min and then resuspended in a selective DMEM D-valine medium (AL251-500ML; HiMedia Laboratories, Thane, India) enriched with 10% FBS, 100 μg/mL streptomycin, 100 U/mL penicillin, 10 μM forskolin and 8 nM NRG1β1 (#396-HB, R&D Systems, Minneapolis, United States) and plated onto poly-L-lysine (PLL) coated culture dishes.

    Techniques: Expressing, Quantitative Proteomics, Quantitative RT-PCR, Gene Expression, RNA Sequencing, Western Blot

    NRG1β1 levels in the patient and control groups before and after antipsychotic drug treatment

    Journal: BMC Psychiatry

    Article Title: Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms

    doi: 10.1186/s12888-022-03856-9

    Figure Lengend Snippet: NRG1β1 levels in the patient and control groups before and after antipsychotic drug treatment

    Article Snippet: Serum NRG1β1 levels were tested using sandwich enzyme-linked immunosorbent assays (ELISAs) in accordance with the manufacturer’s instructions (DY377; R&D Systems, Minneapolis, MN, USA).

    Techniques: Control

    NRG1β1 levels in the responder and nonresponder groups before and after antipsychotic drug treatment

    Journal: BMC Psychiatry

    Article Title: Antipsychotic drugs increase Neuregulin1β1 serum levels in first-episode drug-naïve patients and chronic schizophrenia with suggestions for improving the treatment of psychotic symptoms

    doi: 10.1186/s12888-022-03856-9

    Figure Lengend Snippet: NRG1β1 levels in the responder and nonresponder groups before and after antipsychotic drug treatment

    Article Snippet: Serum NRG1β1 levels were tested using sandwich enzyme-linked immunosorbent assays (ELISAs) in accordance with the manufacturer’s instructions (DY377; R&D Systems, Minneapolis, MN, USA).

    Techniques: